
Keywords: میتوفوزین 1; APL; allosterically potentiating ligand; AD; Alzheimer's disease; Aβ; amyloid-β; ALS; amyotrophic lateral sclerosis; BCCAs; bilateral common carotid arteries stenosis; CTX; cerebral cortex; DAB; diaminobenzidine; Drp1; dynamin-related protein 1; ECTX;